| Net Cash Provided by (Used in) Operating Activities |
$8,900 |
USD |
92% |
Q2 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$4,380 |
USD |
-96% |
Q2 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$0 |
USD |
|
Q2 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
50,000,000,000 |
shares |
0% |
Q3 2025 |
Q2 2026 |
| Common Stock, Shares, Issued |
22,295,726,723 |
shares |
130% |
Q3 2025 |
Q2 2026 |
| Common Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q3 2025 |
Q2 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$546 |
USD |
-92% |
Q3 2025 |
Q2 2026 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$0 |
USD |
|
Q2 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$5,240,101 |
USD |
7.5% |
Q1 2025 |
FY 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$0 |
USD |
|
Q2 2024 |
Q1 2025 |
| Property, Plant and Equipment, Gross |
$1,247,877 |
USD |
0% |
Q3 2025 |
Q2 2026 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$5,240,101 |
USD |
7.5% |
Q1 2025 |
FY 2025 |
| Preferred Stock, Shares Authorized |
1,000,000 |
shares |
0% |
Q3 2025 |
Q2 2026 |
| Additional Paid in Capital |
$55,720,787 |
USD |
-17% |
Q3 2025 |
Q2 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q1 2025 |
FY 2025 |
| Interest Expense |
$412,631 |
USD |
34% |
Q3 2025 |
Q2 2026 |
| Preferred Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
|
Q2 2025 |
Q1 2026 |